Company Overview
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is a global leader in oncology research, conducting clinical trials in the community for over 30 years. Headquartered in the United States, SCRI partners with pharmaceutical and biotech companies, physicians, and patients to advance cancer treatments. With approximately 501 employees, SCRI has contributed to the development of many FDA-approved cancer therapies.
Frequently Asked Questions about Sarah Cannon Research Institute
Technologies Used
Social Profiles
Key Decision Makers
Amy Hammack BSN, RN Clinical Research Coordinator
Erin Jeffers Clinical Trial Manager
Mallori Buresh Clinical Research Coordinator
Tamara Davidson Clinical Research Study Coordinator
Ben Burtness Clinical Research Coordinator II
Hillary Giorgio Lippke Clinical Research Coordinator
Cheryl Edens, CCRP Senior Clinical Research Coordinator
Christy Riggins, M.A. Clinical Research Coordinator